I would say that your got a great price. The number were better than i anticipated. I thought that they would not increase R&D past 1.5 million but instead they increased it to 2.1 million If they had not it would have been another .20 in earnings. The G&A was also reduced which increased earnings by .06 Revenue is starting to creep up by 500k over last year. I believe that new introduction on new product should speed up rev going forward. Remember the 1st Q is over- They most likely earned another .15-.20 for the quarter and increased their cash position and book value. There are plenty of options for this company dividend because of huge cash horde, go totally private and buy back the shares that remain- some 600k would not cost them that much as mentioned at 10 dollars because in a few years they would re-earn that money. Sell the company another option EBITDA for the year is .99 and the stock you purchase was 2.56 crazy cheap could easily trade at 10x EBITDA pe,psr,p/bk, p/cf and zero debt book 7.15 cash over 5$
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.